90 related articles for article (PubMed ID: 3429126)
1. Inhibition of neutrophil aggregation by taeniaestatin, a cestode proteinase inhibitor.
Leid RW; Grant RF; Suquet CM
Int J Parasitol; 1987 Oct; 17(7):1349-53. PubMed ID: 3429126
[No Abstract] [Full Text] [Related]
2. Inhibition of equine neutrophil chemotaxis and chemokinesis by a Taenia taeniaeformis proteinase inhibitor, taeniaestatin.
Leid RW; Grant RF; Suquet CM
Parasite Immunol; 1987 Mar; 9(2):195-204. PubMed ID: 3574975
[TBL] [Abstract][Full Text] [Related]
3. Interleukin inhibition by a parasite proteinase inhibitor, taeniaestatin.
Leid RW; Suquet CM; Bouwer HG; Hinrichs DJ
J Immunol; 1986 Oct; 137(8):2700-2. PubMed ID: 3489773
[TBL] [Abstract][Full Text] [Related]
4. Effect of cytochalasin B on human neutrophil aggregation.
O'Flaherty JT; Kreutzer DL; Ward PA
Exp Cell Res; 1979 Apr; 120(1):31-7. PubMed ID: 374101
[No Abstract] [Full Text] [Related]
5. Hydroxamate-based metalloprotease inhibitor blocks shedding of L-selectin adhesion molecule from leukocytes: functional consequences for neutrophil aggregation.
Bennett TA; Lynam EB; Sklar LA; Rogelj S
J Immunol; 1996 May; 156(9):3093-7. PubMed ID: 8617927
[TBL] [Abstract][Full Text] [Related]
6. Evidence for 5, 12-dihydroxy-6,8,10,14-eicosatetraenoate as a mediator of human neutrophil aggregation.
O'Flaherty JT; Hammett MJ; Shewmake TB; Wykle RL; Love SH; McCall CE; Thomas MJ
Biochem Biophys Res Commun; 1981 Nov; 103(2):552-8. PubMed ID: 6277309
[No Abstract] [Full Text] [Related]
7. Neutrophils degrade subendothelial matrices in the presence of alpha-1-proteinase inhibitor. Cooperative use of lysosomal proteinases and oxygen metabolites.
Weiss SJ; Regiani S
J Clin Invest; 1984 May; 73(5):1297-303. PubMed ID: 6325501
[TBL] [Abstract][Full Text] [Related]
8. Arachidonic acid, leukotriene B4, and neutrophil activation.
Naccache PH; Sha'afi RI
Ann N Y Acad Sci; 1983; 414():125-39. PubMed ID: 6322649
[No Abstract] [Full Text] [Related]
9. Complement-induced granulocyte aggregation.
Camussi G; Cappio FC; Tetta C
N Engl J Med; 1980 Jul; 303(5):285-6. PubMed ID: 7383120
[No Abstract] [Full Text] [Related]
10. Neutrophil aggregation and swelling induced by chemotactic agents.
O'Flaherty JT; Kreutzer DL; Ward PA
J Immunol; 1977 Jul; 119(1):232-9. PubMed ID: 874320
[TBL] [Abstract][Full Text] [Related]
11. Activation of human serum complement with allergens. I. Generation of C3a, C4a, and C5a and induction of human neutrophil aggregation.
Nagata S; Glovsky MM
J Allergy Clin Immunol; 1987 Jul; 80(1):24-32. PubMed ID: 3496373
[TBL] [Abstract][Full Text] [Related]
12. Effects of proteinase inhibitors on polymorphonuclear neutrophil polarization.
Aoshiba K; Nagai A; Takizawa T
Tohoku J Exp Med; 1991 Nov; 165(3):165-70. PubMed ID: 1807003
[TBL] [Abstract][Full Text] [Related]
13. Cathepsin D is released after severe tissue trauma in vivo and is capable of generating C5a in vitro.
Huber-Lang M; Denk S; Fulda S; Erler E; Kalbitz M; Weckbach S; Schneider EM; Weiss M; Kanse SM; Perl M
Mol Immunol; 2012 Feb; 50(1-2):60-5. PubMed ID: 22244896
[TBL] [Abstract][Full Text] [Related]
14. Generation of C5a by phagocytic cells.
Huber-Lang M; Younkin EM; Sarma JV; Riedemann N; McGuire SR; Lu KT; Kunkel R; Younger JG; Zetoune FS; Ward PA
Am J Pathol; 2002 Nov; 161(5):1849-59. PubMed ID: 12414531
[TBL] [Abstract][Full Text] [Related]
15. Modes of action of aspirin-like drugs.
Abramson S; Korchak H; Ludewig R; Edelson H; Haines K; Levin RI; Herman R; Rider L; Kimmel S; Weissmann G
Proc Natl Acad Sci U S A; 1985 Nov; 82(21):7227-31. PubMed ID: 2997778
[TBL] [Abstract][Full Text] [Related]
16. Inhibitors and Antibody Fragments as Potential Anti-Inflammatory Therapeutics Targeting Neutrophil Proteinase 3 in Human Disease.
Korkmaz B; Lesner A; Guarino C; Wysocka M; Kellenberger C; Watier H; Specks U; Gauthier F; Jenne DE
Pharmacol Rev; 2016 Jul; 68(3):603-30. PubMed ID: 27329045
[TBL] [Abstract][Full Text] [Related]
17. Decreased phytohemagglutinin-induced aggregation and C5a-induced chemotaxis of human newborn neutrophils.
Mease AD; Fischer GW; Hunter KW; Ruymann FB
Pediatr Res; 1980 Feb; 14(2):142-6. PubMed ID: 7360528
[TBL] [Abstract][Full Text] [Related]
18. Bdellastasin, a serine protease inhibitor of the antistasin family from the medical leech (Hirudo medicinalis)--primary structure, expression in yeast, and characterisation of native and recombinant inhibitor.
Moser M; Auerswald E; Mentele R; Eckerskorn C; Fritz H; Fink E
Eur J Biochem; 1998 Apr; 253(1):212-20. PubMed ID: 9578479
[TBL] [Abstract][Full Text] [Related]
19. Isolation and partial characterization of a Taenia taeniaeformis metacestode proteinase inhibitor.
Suquet C; Green-Edwards C; Leid RW
Int J Parasitol; 1984 Apr; 14(2):165-72. PubMed ID: 6735579
[No Abstract] [Full Text] [Related]
20. Generation of biologically active, complement-(C5) derived peptides by cathepsin H.
Perez HD; Ohtani O; Banda D; Ong R; Fukuyama K; Goldstein IM
J Immunol; 1983 Jul; 131(1):397-402. PubMed ID: 6408181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
